Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
240.65
+3.30 (1.39%)
At close: Mar 6, 2026, 4:00 PM EST
236.01
-4.64 (-1.93%)
After-hours: Mar 6, 2026, 5:35 PM EST
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $14.77 billion as of March 6, 2026. Its market cap has increased by 57.45% in one year.
Market Cap
14.77B
Enterprise Value
15.07B
1-Year Change
57.45%
Ranking
Category
Stock Price
$240.65
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $14.77B, an increase of 3,191.26%. That is a compound annual growth rate of 36.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 14.77B | 13.38% |
| Dec 31, 2025 | 13.03B | 64.48% |
| Dec 31, 2024 | 7.92B | 9.08% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moderna | 20.74B |
| Roivant Sciences | 20.60B |
| Revolution Medicines | 19.50B |
| Incyte | 19.09B |
| Genmab | 16.50B |
| BridgeBio Pharma | 12.67B |
| Ionis Pharmaceuticals | 12.23B |
| BioMarin Pharmaceutical | 11.75B |